1-3 of 3
Françoise Bridey
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Treatment of Von Willebrand Disease Women Undergoing Childbirth with a Von Willebrand Factor Product with a Low Content of Factor VIII: Results From 4 Multicenter Studies

Catherine Boyer-Neumann, Annie Borel-Derlon, MD, PhD, Jenny Goudemand, MD, PhD, Ségolène Claeyssens, Pierre-Marie Sie, MD, PhD, Philippe Moreau, Marie-Anne Bertrand, MD, Chantal Rothschild, MD, Benoît Guillet, MD, PhD, Jeanne Yvonne Borg, Catherine Chatelanaz, Wil Stevens, Françoise Bridey, Celine Henriet
Journal: Blood
Blood (2012) 120 (21): 3375.
https://doi.org/10.1182/blood.V120.21.3375.3375
Published: 2012
Journal Articles

Clinical Use of a Von Willebrand Factor with a Low FVIII Content in Von Willebrand Disease Patients Undergoing Surgical Procedures or Deliveries: Results From 5 Prospective Multicenter Studies

Annie Borel-Derlon, MD, PhD, Augusto B. Federici, MD, Jenny Goudemand, MD, PhD, Catherine Chatelanaz, Celine Henriet, Françoise Bridey
Journal: Blood
Blood (2011) 118 (21): 383.
https://doi.org/10.1182/blood.V118.21.383.383
Published: 2011
Journal Articles

French Multicenter Study for Post-Marketing Survey of WILFACTIN®: A Von Willebrand Factor Concentrate with a Low FVIII Content.

Annie Borel-Derlon, Jenny Goudemand, Chantal Rothschild, Catherine Chatelanaz, Françoise Bridey, French Post-Marketing Study Group5
Journal: Blood
Blood (2006) 108 (11): 4052.
https://doi.org/10.1182/blood.V108.11.4052.4052
Published: 2006